Observational studyJapanese journal of clinical oncology2024

First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.

Hisao Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.